Biogen Idec, Elan Rerelease Tysabri

MSN Money - USA
... said Monday its multiple sclerosis treatment Tysabri is now available in the US 17 months after the companies pulled the drug from pharmacies. ...
See all stories on this topic

Elan -2.8%, Mkt Awaits Concrete Tysabri Data
newratings.com - USA
0920 GMT [Dow Jones] Elan (ELN) -2.8% at EUR10.40 after saying it launched MS drug Tysabri for relapsing patients the US and in 4 EU countries. ...
See all stories on this topic

10.45am Markets Update
RTE.ie - Ireland
... ahead. In Dublin, Elan fell 10 cent to €10.60 as it announced that its MS drug Tysabri was now available again in the US. Drinks ...